JP2002038158A - Method for orienting liquid crystal molecule - Google Patents
Method for orienting liquid crystal moleculeInfo
- Publication number
- JP2002038158A JP2002038158A JP2000221114A JP2000221114A JP2002038158A JP 2002038158 A JP2002038158 A JP 2002038158A JP 2000221114 A JP2000221114 A JP 2000221114A JP 2000221114 A JP2000221114 A JP 2000221114A JP 2002038158 A JP2002038158 A JP 2002038158A
- Authority
- JP
- Japan
- Prior art keywords
- liquid crystal
- crystal molecules
- quaternary salt
- pyridinium
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 117
- 238000000034 method Methods 0.000 title claims abstract description 61
- 239000000758 substrate Substances 0.000 claims abstract description 44
- 150000003839 salts Chemical group 0.000 claims abstract description 34
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims abstract description 32
- 125000001931 aliphatic group Chemical group 0.000 claims description 26
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 239000004985 Discotic Liquid Crystal Substance Substances 0.000 claims description 8
- 150000001450 anions Chemical group 0.000 claims description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- 125000005580 triphenylene group Chemical group 0.000 claims description 3
- 239000010410 layer Substances 0.000 description 38
- 150000001875 compounds Chemical class 0.000 description 19
- 239000010408 film Substances 0.000 description 14
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 12
- -1 chromium carboxylate Chemical class 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 239000011521 glass Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229940126214 compound 3 Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 125000000547 substituted alkyl group Chemical group 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 238000004528 spin coating Methods 0.000 description 4
- 125000005017 substituted alkenyl group Chemical group 0.000 description 4
- 229920002284 Cellulose triacetate Polymers 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 125000004426 substituted alkynyl group Chemical group 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 239000004642 Polyimide Substances 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229920001721 polyimide Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- ITOFPJRDSCGOSA-KZLRUDJFSA-N (2s)-2-[[(4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H](CC[C@]13C)[C@@H]2[C@@H]3CC[C@@H]1[C@H](C)CCC(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 ITOFPJRDSCGOSA-KZLRUDJFSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004962 Polyamide-imide Substances 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000002858 crystal cell Anatomy 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000007765 extrusion coating Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000005268 rod-like liquid crystal Substances 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000007767 slide coating Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000003431 steroids Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
Landscapes
- Liquid Crystal (AREA)
- Pyridine Compounds (AREA)
- Liquid Crystal Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、配向傾斜角が制御
できる液晶分子の配向方法に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for aligning liquid crystal molecules in which the angle of alignment can be controlled.
【0002】[0002]
【従来の技術】液晶性化合物は液晶層において液体のよ
うな流動性と結晶のような規則的な分子配列を併せ持つ
性質を示すことから様々な分野で応用展開が期待されて
おり、その分子配列の制御は液晶ディスプレイに代表さ
れる液晶デバイスへの工学的応用に欠かせないものとな
っている。特に、プレチルト角をはじめとする傾斜角の
制御は現在の液晶配向技術の重要な課題の一つとなって
いる。2. Description of the Related Art Since liquid crystal compounds exhibit both liquid-like fluidity and crystal-like regular molecular arrangement in a liquid crystal layer, they are expected to be applied in various fields. Control is indispensable for engineering application to liquid crystal devices represented by liquid crystal displays. In particular, control of the tilt angle including the pretilt angle is one of the important issues of the current liquid crystal alignment technology.
【0003】液晶の分子配向は代表的なものとして、
1)ホメオトロピック配向、2)ホモジニアス配向、
3)ティルト配向、4)ハイブリッド配向、5)ツイス
ド配向、6)プレーナ配向、7)フォーカルコニック配
向の7種が知られており、詳しくは「液晶の基礎と応
用」、工業調査会出版(1991年)に記載されてい
る。[0003] The molecular orientation of liquid crystal is a typical one.
1) homeotropic alignment, 2) homogeneous alignment,
Three types are known: 3) tilt alignment, 4) hybrid alignment, 5) twisted alignment, 6) planar alignment, and 7) focal conic alignment. For more details, "Basic and Application of Liquid Crystal", Industrial Research Institute Publishing (1991) Year).
【0004】一般に、どんな種類の配向が得られるか
は、用いる液晶が決まれば基板表面にどんな配向処理が
施されるかで決定する。配向処理には様々な方法が提案
されており、これらは液晶の基礎と応用」、工業調査会
出版(1991年)に詳しく記載されている。例えば、
垂直、あるいは平行配向させる方法として、Appl. Phy
s. Lett.誌、第27巻、268頁(1975年)、 App
l. Phys. Lett.誌、第29巻、67頁(1976年)、
Appl. Phys. Lett.誌、第22巻、111頁(1973
年)等にはカルボン酸クロム錯体や有機シラン等の配向
剤を基板面に化学吸着させる方法、 応用物理誌、第4
3巻、18頁(1974年)、 Phys. Rev.Lett.誌、第
25巻、67頁(1976年)等には配向剤を基板面に
物理吸着させる方法、Appl. Phys. Lett.誌、第24
巻、297頁(1974年)等には低分子量物質をプラ
ズマ放電で基板面に重合付着させる方法、J. Appl. Phy
s.誌、第47、1270頁(1976年)等には高分子
量物質を高電界の作用で基板面に重合付着させる方法が
開示されている。次に、傾斜平行配向させる方法として
Appl. Phys. Lett.誌、第25巻、479頁(1974
年)等には基板面に斜めの角度から酸化珪素等の酸化物
を蒸着させる斜め蒸着法が、傾斜垂直配向させる方法と
して前記の斜め蒸着法と垂直配向剤を併用する方法が開
示されている。傾斜垂直配向させる方法としては、他に
基板面を回転させながら斜めの角度から酸化珪素等の酸
化物を蒸着させる斜め蒸着法が第6回液晶討論会要旨
集、96頁(1980年)に開示されている。この方法
では、一定の傾斜配向角を有する安定した配向は得られ
るものの工業的に製造するには生産性が悪く、大面積化
が困難であるなどの問題が生じる。In general, what kind of alignment can be obtained depends on what kind of alignment treatment is to be performed on the substrate surface if the liquid crystal to be used is determined. Various methods have been proposed for the alignment treatment, which are described in detail in "Basics and Applications of Liquid Crystals", published by the Industrial Research Institute (1991). For example,
Appl. Phy for vertical or parallel orientation
s. Lett., 27, 268 (1975), App
l. Phys. Lett., Vol. 29, p. 67 (1976),
Appl. Phys. Lett., Vol. 22, p. 111 (1973)
), A method of chemically adsorbing an aligning agent such as a chromium carboxylate complex or an organic silane onto a substrate surface.
3, 18 (1974), Phys. Rev. Lett., Vol. 25, p. 67 (1976), and the like, a method of physically adsorbing an aligning agent on a substrate surface, Appl. Phys. Lett. 24th
Vol., P. 297 (1974), etc., a method of polymerizing a low molecular weight substance onto a substrate surface by plasma discharge, J. Appl. Phy.
s., 47, 1270 (1976) and the like disclose a method of polymerizing a high molecular weight substance onto a substrate surface by the action of a high electric field. Next, as a method of tilting parallel alignment
Appl. Phys. Lett., 25, 479 (1974)
For example, the oblique deposition method of depositing an oxide such as silicon oxide on a substrate surface from an oblique angle is disclosed in Japanese Patent Application Laid-Open No. H11-146572. . As another method for oblique vertical alignment, an oblique vapor deposition method in which an oxide such as silicon oxide is vapor-deposited from an oblique angle while rotating the substrate surface is disclosed in the 6th Meeting of the Liquid Crystal Symposium, p. 96 (1980). Have been. According to this method, although stable orientation having a certain tilt orientation angle can be obtained, there are problems such as low productivity for industrial production and difficulty in increasing the area.
【0005】分子を配向させる手法としては基板表面に
有機被膜をもうけ、その表面を綿、ナイロン、ポリエス
テル等の布で一定方向にラビングし、ラビング方向に液
晶分子を配向させる方法がある。この方法は、比較的容
易に安定した配向が得られるため、工業的には専らこの
方法が採用されている。有機膜としては、ポリビニルア
ルコール、ポリオキシエチレン、ポリアミド、ポリイミ
ド等が挙げられるが、化学的安定性、熱的安定性等の点
からポリイミドが最も一般的に使用されている。この様
な液晶配向膜では、用いる配向膜により液晶分子の傾斜
角が変わることが知られている。例えば、特開平5−4
3687号、同8−12759号、同8−220541
号、同8−220542号、同9−143196号、同
9−230354号、同9−278724号、同10−
45690号、同10−123532号には傾斜配向可
能な種々の配向膜が開示されている。しかし、傾斜角は
配向膜自身の性質に依存するものであり、その角度を容
易に調整できるものではなかった。また、光により液晶
分子の配向を制御する方法も知られている。例えば、機
能材料、第17巻、13頁(1997年)には、光によ
り傾斜角を制御できる様々な配向膜が記載されている。
しかしながら、これらの手法は、偏光照射や偏光紫外線
照射を用いる必要があったり、傾斜角の調整に偏光の入
射角を変える変化させる必要があったり、必ずしも容易
に傾斜角を制御できるものではなかった。As a method of aligning molecules, there is a method of forming an organic film on the substrate surface, rubbing the surface with a cloth such as cotton, nylon, polyester or the like in a certain direction, and aligning the liquid crystal molecules in the rubbing direction. In this method, a stable orientation can be obtained relatively easily, and therefore, this method is exclusively used industrially. Examples of the organic film include polyvinyl alcohol, polyoxyethylene, polyamide, and polyimide. Among them, polyimide is most commonly used in terms of chemical stability, thermal stability, and the like. In such a liquid crystal alignment film, it is known that the tilt angle of liquid crystal molecules changes depending on the alignment film used. For example, JP-A-5-4
Nos. 3687, 8-12759 and 8-220541
Nos. 8-220542, 9-143196, 9-230354, 9-278724, and 10-
Nos. 45690 and 10-123532 disclose various alignment films capable of tilt alignment. However, the tilt angle depends on the properties of the alignment film itself, and the angle cannot be easily adjusted. A method of controlling the alignment of liquid crystal molecules by light is also known. For example, in Functional Materials, Vol. 17, p. 13 (1997), various alignment films whose tilt angle can be controlled by light are described.
However, these methods need to use polarized light irradiation or polarized ultraviolet light irradiation, or need to change the incident angle of polarized light to adjust the inclination angle, and cannot always easily control the inclination angle. .
【0006】以上のように様々な配向技術が提案され、
液晶性化合物を傾斜配向させる技術も開示されている。
しかしながら、傾斜角の制御という観点からはいずれも
十分ではなく、容易に液晶性化合物の配列傾斜角を制御
できる方法の開発が望まれていた。As described above, various orientation techniques have been proposed.
A technique for tilt-aligning a liquid crystal compound has also been disclosed.
However, none of them is sufficient from the viewpoint of controlling the tilt angle, and there has been a demand for the development of a method capable of easily controlling the tilt angle of the liquid crystal compound.
【0007】[0007]
【発明が解決しようとする課題】本発明の課題は、液晶
性化合物の配向傾斜角を容易に制御することにある。SUMMARY OF THE INVENTION An object of the present invention is to easily control the tilt angle of the liquid crystal compound.
【0008】[0008]
【発明が解決するための手段】本発明は、下記(1)〜
(4)の液晶分子の配向方法を提供する。 (1)基板上に液晶分子を含む液晶層を形成し、液晶分
子を配向させる方法であって、液晶層または隣接する層
に、ピリジニウム四級塩を添加し、ピリジニウム四級塩
の作用により液晶分子の傾斜角を制御することを特徴と
する液晶分子の配向方法。 (2)ピリジニウム四級塩のピリジニウム環が、脂肪族
アミノ基を置換基として有する請求項1に記載の液晶分
子の配向方法。 (3)ピリジニウム四級塩が、下記式(I)で表される
(1)に記載の液晶分子の配向方法:The present invention provides the following (1) to
(4) A method for aligning liquid crystal molecules is provided. (1) A method of forming a liquid crystal layer containing liquid crystal molecules on a substrate and orienting the liquid crystal molecules, wherein a pyridinium quaternary salt is added to the liquid crystal layer or an adjacent layer, and the liquid crystal is formed by the action of the pyridinium quaternary salt. A method for aligning liquid crystal molecules, comprising controlling the tilt angle of molecules. (2) The method for aligning liquid crystal molecules according to claim 1, wherein the pyridinium ring of the pyridinium quaternary salt has an aliphatic amino group as a substituent. (3) The method for aligning liquid crystal molecules according to (1), wherein the pyridinium quaternary salt is represented by the following formula (I):
【0009】[0009]
【化3】 Embedded image
【0010】[式中、R1 は、炭素原子数が1乃至30
の脂肪族基であり;R2 およびR3 は、それぞれ独立
に、炭素原子数が1乃至8の脂肪族基であるか、あるい
は、R2とR3 とが結合して含窒素複素環を形成し;そ
して、Xは、アニオンである]。 (4)ピリジニウム四級塩が、下記式(II)で表される
(1)に記載の液晶分子の配向方法:Wherein R 1 has 1 to 30 carbon atoms.
R 2 and R 3 are each independently an aliphatic group having 1 to 8 carbon atoms, or R 2 and R 3 are bonded to form a nitrogen-containing heterocyclic ring; And X is an anion]. (4) The method for aligning liquid crystal molecules according to (1), wherein the pyridinium quaternary salt is represented by the following formula (II):
【0011】[0011]
【化4】 Embedded image
【0012】[式中、R1 は、炭素原子数が1乃至30
の脂肪族基であり;R2 およびR3 は、それぞれ独立
に、炭素原子数が1乃至8の脂肪族基であるか、あるい
は、R2とR3 とが結合して含窒素複素環を形成し;そ
して、Xは、アニオンである]。 (5)ピリジニウム塩を、液晶分子に対するモル比で1
/1000乃至250/1000の範囲で用いる(1)
に記載の液晶分子の配向方法。 (6)液晶分子がディスコティック液晶分子である
(1)に記載の液晶分子の配向方法。 (7)液晶分子がトリフェニレン核を有する(1)に記
載の液晶分子の配向方法。[Wherein, R 1 has 1 to 30 carbon atoms.
R 2 and R 3 are each independently an aliphatic group having 1 to 8 carbon atoms, or R 2 and R 3 are bonded to form a nitrogen-containing heterocyclic ring; And X is an anion]. (5) The pyridinium salt is used in a molar ratio of 1 to the liquid crystal molecules.
Use in the range of / 1000 to 250/1000 (1)
3. The method for aligning liquid crystal molecules according to item 1. (6) The method for aligning liquid crystal molecules according to (1), wherein the liquid crystal molecules are discotic liquid crystal molecules. (7) The method for aligning liquid crystal molecules according to (1), wherein the liquid crystal molecules have a triphenylene nucleus.
【0013】[0013]
【発明の実施の形態】本明細書において、基板とは液晶
層をのせる材料、あるいは液晶セルの構成要素となる液
晶層をはさむ材料を示す。具体的には、トリアセチルセ
ルロース(TAC)フイルム、 ポリエチレンナフタレ
ート(PEN)フイルムのようなポリマーフイルムを用
いる。また、ガラス板、ITO基板、カラーフィルター
基板、水晶板、シリコンウェファー、偏光板を、基板と
して用いることができる。基板には、配向層、透明電極
(ITO)、カラーフィルター層、ブラックマトリック
ス、薄膜トランジスタを設けてもよい。また、電極パタ
ーン形成や前記に記すようなラビング処理、偏光UB照
射などの配向処理を行ってもよい。用いる基板は単独で
も一対でもよく、一対で用いる場合は必要に応じてスペ
ーサー、シール剤等を用いてもよい。本明細書におい
て、液晶層に隣接する層とは、基板と液晶層の間に位置
する層のうち、最も液晶層に近い層であることが好まし
い。液晶層に隣接する層は、配向膜あるいは透明電極と
しての機能を有していてもよい。DESCRIPTION OF THE PREFERRED EMBODIMENTS In this specification, a substrate refers to a material for mounting a liquid crystal layer or a material for sandwiching a liquid crystal layer which is a component of a liquid crystal cell. Specifically, a polymer film such as a triacetyl cellulose (TAC) film or a polyethylene naphthalate (PEN) film is used. In addition, a glass plate, an ITO substrate, a color filter substrate, a quartz plate, a silicon wafer, and a polarizing plate can be used as the substrate. The substrate may be provided with an alignment layer, a transparent electrode (ITO), a color filter layer, a black matrix, and a thin film transistor. Further, an alignment process such as the formation of an electrode pattern, the rubbing process described above, and the irradiation of polarized UB may be performed. A single substrate or a pair of substrates may be used. When a pair is used, a spacer, a sealant, or the like may be used as necessary. In this specification, the layer adjacent to the liquid crystal layer is preferably a layer closest to the liquid crystal layer among layers located between the substrate and the liquid crystal layer. The layer adjacent to the liquid crystal layer may have a function as an alignment film or a transparent electrode.
【0014】液晶層は主に液晶分子で構成される。液晶
分子としては、ディスコティック液晶分子、棒状液晶分
子、コレステリック液晶分子が好ましい。ディスコテッ
ク液晶性分子が特に好ましい。ディスコテック液晶分子
は、トリフェニレン核を有することが好ましい。二種類
以上の液晶性分子を併用してもよい。液晶層には、液晶
分子以外の成分(例、色素、二色色素、高分子、重合
剤、増感剤、相転移温度低下材、安定剤)を添加しても
よい。液晶層を基板上に設ける方法としては、周知の方
法が採用される。塗布する方式としては、公知の方法、
例えばカーテンコーティング法、押し出しコーティング
法、ロールコーティング法、スピンコーティング法、デ
ィップコーティング法、、バーコーティング法、スプレ
ーコーティング法、スライドコーティング法、印刷コー
ティング法等が採用される。この時、基板は前記のよう
な必要な処理、配向層をはじめとする必要な層、部位を
設けてもよい。液晶分子を基板間に注入する方法として
は、ディスペンサー方式、ベルジャー法などの一般的な
方法が採用される。また、基板に液晶層を塗布し、別の
基板、あるいは別の液晶層を塗布した基板を併せてもよ
い。The liquid crystal layer is mainly composed of liquid crystal molecules. As the liquid crystal molecules, discotic liquid crystal molecules, rod-like liquid crystal molecules, and cholesteric liquid crystal molecules are preferable. Discotech liquid crystalline molecules are particularly preferred. The discotec liquid crystal molecules preferably have a triphenylene nucleus. Two or more liquid crystal molecules may be used in combination. Components other than liquid crystal molecules (eg, dyes, dichroic dyes, polymers, polymerizers, sensitizers, phase transition temperature lowering materials, stabilizers) may be added to the liquid crystal layer. As a method for providing the liquid crystal layer on the substrate, a known method is employed. As a method of applying, a known method,
For example, curtain coating, extrusion coating, roll coating, spin coating, dip coating, bar coating, spray coating, slide coating, print coating, and the like are employed. At this time, the substrate may be provided with necessary layers and portions including the necessary processing and alignment layers as described above. As a method of injecting liquid crystal molecules between the substrates, a general method such as a dispenser method or a bell jar method is employed. Further, a liquid crystal layer may be applied to a substrate, and another substrate or a substrate to which another liquid crystal layer is applied may be combined.
【0015】本発明では、ピリジニウム四級塩を用い
て、その作用により液晶分子の傾斜角を制御する。ピリ
ジニウム四級塩を添加すると、一般に液晶分子の傾斜角
が上昇する。その結果として、液晶分子の傾斜角を制御
することができる。ピリジニウム四級塩のピリジニウム
環は、脂肪族アミノ基を置換基として有することが好ま
しい。脂肪族アミノ基の置換位置は、4位であることが
好ましい。ピリジニウム環は、脂肪族アミノ基以外に、
他の置換基(アミノ、ヒドロキシル、チオール、カルボ
キシル、アルキル基、アルコキシ基、ハロゲン原子)を
有していてもよい。ピリジニウム四級塩のN−置換基
(窒素原子に結合する基)は、脂肪族基であることが好
ましい。脂肪族基には、アルキル基、置換アルキル基、
アルケニル基、置換アルケニル基、アルキニル基および
置換アルキニル基が含まれる。脂肪族基は、環状構造を
有しててもよい。鎖状脂肪族基は分岐を有していてもよ
い。脂肪族基の置換基の例には、アリール基、アルコキ
シ基、アルキルチオ基、アミド基、アシル基、アシルオ
キシ基、アルコキシカルボニル基、カルボキシル、ハロ
ゲン原子、アルコキシアルキル基、アルキルオキシオキ
シカルボニルアルキル基、2,2,3,3,4,4,
5,5,6,6,7,7,8,8,8−ペンタデカフル
オロオクチルオキシカルボニルエチルが含まれる。ピリ
ジニウム四級塩の対イオンとなる陰イオンの例には、フ
ッ素イオン、塩素イオン、臭素イオン、ヨウ素イオン、
ベンゼンスルホニウムイオンおよびパラトルエンスルホ
ニウムイオンが含まれる。下記式(I)で表されるピリ
ジニウム四級塩が、好ましい。In the present invention, the inclination angle of the liquid crystal molecules is controlled by using a pyridinium quaternary salt. Addition of a pyridinium quaternary salt generally increases the tilt angle of liquid crystal molecules. As a result, the tilt angle of the liquid crystal molecules can be controlled. The pyridinium ring of the pyridinium quaternary salt preferably has an aliphatic amino group as a substituent. The substitution position of the aliphatic amino group is preferably the 4-position. Pyridinium ring, other than the aliphatic amino group,
It may have another substituent (amino, hydroxyl, thiol, carboxyl, alkyl group, alkoxy group, halogen atom). The N-substituent (group bonded to the nitrogen atom) of the pyridinium quaternary salt is preferably an aliphatic group. Aliphatic groups include alkyl groups, substituted alkyl groups,
Includes alkenyl, substituted alkenyl, alkynyl and substituted alkynyl groups. The aliphatic group may have a cyclic structure. The chain aliphatic group may have a branch. Examples of the substituent of the aliphatic group include an aryl group, an alkoxy group, an alkylthio group, an amide group, an acyl group, an acyloxy group, an alkoxycarbonyl group, a carboxyl, a halogen atom, an alkoxyalkyl group, an alkyloxyoxycarbonylalkyl group, and , 2,3,3,4,4
5,5,6,6,7,7,8,8,8-pentadecafluorooctyloxycarbonylethyl. Examples of anions serving as counterions of pyridinium quaternary salts include fluorine ions, chloride ions, bromine ions, iodine ions,
Includes benzenesulfonium ions and paratoluenesulfonium ions. Pyridinium quaternary salts represented by the following formula (I) are preferred.
【0016】[0016]
【化5】 Embedded image
【0017】式(I)において、R1 は、炭素原子数が
1乃至30の脂肪族基である。脂肪族基には、アルキル
基、置換アルキル基、アルケニル基、置換アルケニル
基、アルキニル基および置換アルキニル基が含まれる。
脂肪族基は、環状構造を有しててもよい。環状脂肪族基
には、ステロイド構造を有する基も含まれる。鎖状脂肪
族基は分岐を有していてもよい。脂肪族基の置換基の例
には、アリール基、アルコキシ基、アルキルチオ基、ア
ミド基、アシル基、アシルオキシ基、アルコキシカルボ
ニル基、カルボキシル、ハロゲン原子、アルコキシアル
キル基、アルキルオキシオキシカルボニルアルキル基、
2,2,3,3,4,4,5,5,6,6,7,7,
8,8,8−ペンタデカフルオロオクチルオキシカルボ
ニルエチルが含まれる。In the formula (I), R 1 is an aliphatic group having 1 to 30 carbon atoms. Aliphatic groups include alkyl groups, substituted alkyl groups, alkenyl groups, substituted alkenyl groups, alkynyl groups, and substituted alkynyl groups.
The aliphatic group may have a cyclic structure. The cycloaliphatic group includes a group having a steroid structure. The chain aliphatic group may have a branch. Examples of the substituent of the aliphatic group include an aryl group, an alkoxy group, an alkylthio group, an amide group, an acyl group, an acyloxy group, an alkoxycarbonyl group, a carboxyl, a halogen atom, an alkoxyalkyl group, an alkyloxyoxycarbonylalkyl group,
2,2,3,3,4,4,5,5,6,6,7,7,
8,8,8-Pentadecafluorooctyloxycarbonylethyl is included.
【0018】式(I)において、R2 およびR3 は、そ
れぞれ独立に、炭素原子数が1乃至8の脂肪族基である
か、あるいは、R2 とR3 とが結合して含窒素複素環を
形成する。脂肪族基は、アルキル基、置換アルキル基、
アルケニル基、置換アルケニル基、アルキニル基および
置換アルキニル基を含む。環状脂肪族基よりも鎖状脂肪
族基の方が好ましい。R2 およびR3 は、それぞれ独立
に、アルキル基、置換アルキル基、アルケニル基または
置換アルケニル基であることが好ましく、アルキル基ま
たは置換アルキル基であることがさらに好ましく、アル
キル基であることが最も好ましい。R2 およびR3 の炭
素原子数は、1乃至7であることが好ましく、1乃至5
であることがさらに好ましく、1乃至4であることが最
も好ましい。脂肪族基の例には、メチル、エチル、n−
プロピル、イソプロピル、シクロプロピル、n−ブチ
ル、sec-ブチル、t−ブチル基、シクロブチル基、シク
ロプロピルメチル、n−ペンチル、ネオペンチル、n−
ヘキシル、シクロヘキシルおよびn−ヘプチルが含まれ
る。R2 とR3 とが結合して形成する含窒素複素環は、
5員環または6員環であることが好ましい。In the formula (I), R 2 and R 3 are each independently an aliphatic group having 1 to 8 carbon atoms, or a nitrogen-containing complex in which R 2 and R 3 are bonded to each other. Form a ring. An aliphatic group is an alkyl group, a substituted alkyl group,
Includes alkenyl, substituted alkenyl, alkynyl and substituted alkynyl groups. A chain aliphatic group is preferred over a cyclic aliphatic group. R 2 and R 3 are each independently preferably an alkyl group, a substituted alkyl group, an alkenyl group or a substituted alkenyl group, more preferably an alkyl group or a substituted alkyl group, and most preferably an alkyl group. preferable. R 2 and R 3 preferably have 1 to 7 carbon atoms, and preferably have 1 to 5 carbon atoms.
Is more preferable, and most preferably 1 to 4. Examples of aliphatic groups include methyl, ethyl, n-
Propyl, isopropyl, cyclopropyl, n-butyl, sec-butyl, t-butyl group, cyclobutyl group, cyclopropylmethyl, n-pentyl, neopentyl, n-
Hexyl, cyclohexyl and n-heptyl are included. The nitrogen-containing heterocyclic ring formed by combining R 2 and R 3 is
It is preferably a 5- or 6-membered ring.
【0019】式(I)において、Xは、アニオンであ
る。アニオンの例には、塩素イオン、臭素イオン、ヨウ
素イオン、p−トルエンスルホニウムイオンおよびベン
ゼンスルホニウムイオンが含まれる。下記式(II)で表
されるピリジニウム四級塩が、さらに好ましい。In the formula (I), X is an anion. Examples of anions include chloride, bromine, iodine, p-toluenesulfonium and benzenesulfonium. Pyridinium quaternary salts represented by the following formula (II) are more preferred.
【0020】[0020]
【化6】 Embedded image
【0021】式(II)において、R1 、R2 、R3 およ
びXは、式(I)と同様の定義を有する。以下に、ピリ
ジニウム四級塩の例を示す。In the formula (II), R 1 , R 2 , R 3 and X have the same definition as in the formula (I). Below, the example of a pyridinium quaternary salt is shown.
【0022】[0022]
【化7】 Embedded image
【0023】[0023]
【化8】 Embedded image
【0024】[0024]
【化9】 Embedded image
【0025】[0025]
【化10】 Embedded image
【0026】[0026]
【化11】 Embedded image
【0027】[0027]
【化12】 Embedded image
【0028】[0028]
【化13】 Embedded image
【0029】[0029]
【化14】 Embedded image
【0030】液晶層に隣接してなる層にピリジニウム四
級塩を添加する方法の例としては、基板上に液晶層に隣
接してなる層を形成するための塗布液にピリジニウム四
級塩を添加する方法や液晶層に隣接してなる層としてピ
リジニウム四級塩の溶液を直接塗布する方法などが挙げ
られるが、液晶層に隣接してなる層を形成するための塗
布液にピリジニウム四級塩を添加する方法が好ましい。
添加量は、液晶の配向を乱さない範囲で目的とする傾斜
角に適切な量を添加することが採用されるが、用いる液
晶分子に対してモル比で1/1000から250/10
00の範囲で添加することが好ましい例として採用され
る。塗布方式としては、前述の液晶層の塗布方式の例が
挙げられる。液晶層自体にピリジニウム四級塩を添加す
る方法の例としては、基板上に液晶層を塗布形成した後
にピリジニウム四級塩、または該四級塩を含む溶液を添
加する方法や1対の基板間に液晶分子を注入した後にピ
リジニウム四級塩、または該四級塩を含む溶液をを添加
する方法などが採用される。As an example of the method of adding a pyridinium quaternary salt to a layer adjacent to a liquid crystal layer, there is a method of adding a pyridinium quaternary salt to a coating solution for forming a layer adjacent to a liquid crystal layer on a substrate. And a method of directly applying a solution of a pyridinium quaternary salt as a layer adjacent to the liquid crystal layer.However, a pyridinium quaternary salt is used in a coating solution for forming a layer adjacent to the liquid crystal layer. The addition method is preferred.
As for the amount of addition, it is adopted that an appropriate amount is added to the target tilt angle within a range that does not disturb the alignment of the liquid crystal, but the molar ratio is 1/1000 to 250/10 with respect to the liquid crystal molecules used.
It is adopted as a preferable example that it is added in the range of 00. Examples of the coating method include the above-described examples of the liquid crystal layer coating method. Examples of the method of adding the pyridinium quaternary salt to the liquid crystal layer itself include a method of adding a pyridinium quaternary salt or a solution containing the quaternary salt after coating and forming the liquid crystal layer on a substrate, or a method of adding a solution containing a pair of substrates. And then adding a pyridinium quaternary salt or a solution containing the quaternary salt after injecting liquid crystal molecules into the liquid crystal.
【0031】液晶分子を基板間に注入する液に添加する
方法の例としては、通常の方法で製造される液晶の注入
液に液晶の配向を乱さない範囲で目的とする傾斜角に適
切な量のピリジニウム四級塩を添加することが採用され
る。このとき、他の添加剤を併用してもよい。添加量は
液晶の配向を乱さない範囲では限定されないが、用いる
液晶分子に対してモル比で1/1000から25/10
0の範囲で添加することが好ましい例として採用され
る。液晶分子を基板に塗布する液に添加する方法として
は、通常の方法で製造される液晶の塗布液に液晶の配向
を乱さない範囲で目的とする傾斜角に適切な量のピリジ
ニウム四級塩を添加することが採用される。このとき、
他の添加剤を併用してもよい。添加量は液晶の配向を乱
さない範囲では限定されないが、用いる液晶分子に対し
てモル比で1/1000から25/100の範囲で添加
することが好ましい例として採用される。As an example of a method of adding liquid crystal molecules to a liquid to be injected between substrates, a liquid crystal injection liquid produced by an ordinary method may be added in an amount suitable for a desired tilt angle within a range that does not disturb the alignment of the liquid crystal. The addition of a pyridinium quaternary salt of At this time, other additives may be used in combination. The amount of addition is not limited as long as it does not disturb the alignment of the liquid crystal, but it is 1/1000 to 25/10 in molar ratio to the liquid crystal molecules used.
It is adopted as a preferable example that the addition is performed in the range of 0. As a method of adding liquid crystal molecules to a liquid applied to a substrate, an appropriate amount of a pyridinium quaternary salt for a desired tilt angle within a range that does not disturb the alignment of the liquid crystal is applied to a liquid crystal coating liquid manufactured by an ordinary method. Addition is employed. At this time,
Other additives may be used in combination. The amount of addition is not limited as long as it does not disturb the orientation of the liquid crystal, but it is preferably added in a molar ratio of 1/1000 to 25/100 with respect to the liquid crystal molecules used.
【0032】[0032]
【実施例】[実施例1] (液晶傾斜角制御能の評価)特開平8−48197号公
報記載のメタクリロイルオキシイソシアネートで修飾し
たポリビニルアルコールの水溶液をガラス基板(厚さ:
0.85mm)にバーコーターで塗布し、乾燥、ラビング
処理を行った。次に、メチルエチルケトン400重量部
に下記のディスコティック液晶化合物(DLC)100
重量部、セルロース アセテート ブチレート1重量部
とピリジニウム四級塩0.05重量部を溶解した液をス
ピンコートで塗布した後、室温で乾燥した。液晶層を2
00度に加熱した後、130度で液晶化合物を配向し、
その状態で基板を急速に室温まで冷却して配向状態を固
定した。そして、得られた薄膜のレタデーションが最小
となる方向の角度を測定することにより、その液晶分子
の平均傾斜角を算出した。[Example 1] (Evaluation of liquid crystal tilt angle controllability) An aqueous solution of polyvinyl alcohol modified with methacryloyloxyisocyanate described in JP-A-8-48197 was coated on a glass substrate (thickness:
(0.85 mm) with a bar coater, and dried and rubbed. Next, the following discotic liquid crystal compound (DLC) 100 was added to 400 parts by weight of methyl ethyl ketone.
A solution prepared by dissolving 1 part by weight of cellulose acetate butyrate and 0.05 part by weight of a pyridinium quaternary salt was applied by spin coating, followed by drying at room temperature. Liquid crystal layer 2
After heating to 00 degrees, the liquid crystal compound is aligned at 130 degrees,
In this state, the substrate was rapidly cooled to room temperature to fix the alignment state. The average tilt angle of the liquid crystal molecules was calculated by measuring the angle of the obtained thin film in the direction in which the retardation was minimized.
【0033】[0033]
【化15】 Embedded image
【0034】 使用傾斜制御剤 平均傾斜角 未使用 27度 化合物2 33度 化合物3 34度Used tilt controlling agent Average tilt angle Unused 27 degrees Compound 2 33 degrees Compound 3 34 degrees
【0035】[実施例2] (液晶傾斜角制御能の評価)厚さ100μm、サイズ2
70mm×100mmのトリアセチルセルロースフイル
ム(フジタック、富士写真フイルム(株)製)を基板と
して用いた。基板上にアルキル変性ポリビニルアルコー
ル(MP-203、クラレ(株)製)を0.5μmの厚さに
塗布し、乾燥、ラビング処理を行った。次に、メチルエ
チルケトン400重量部に実施例1で用いたディスコテ
ィック液晶化合物(DLC)100重量部、下記のフッ
素系モノマーM−1およびM−2から得られるコポリマ
ー1重量部、下記の多官能モノマー(M−3)10重量
部とピリジニウム四級塩を溶解した液をバーコーターを
用いて塗布した後、室温で乾燥した。塗布層を125度
に加熱して液晶化合物を配向させ、基板を急速に室温ま
で冷却してその配向状態を固定した。そして、得られた
薄膜のレタデーションが最小となる方向の角度を測定す
ることにより、その液晶分子の平均傾斜角を算出した。Example 2 (Evaluation of liquid crystal tilt angle controllability) Thickness 100 μm, size 2
A 70 mm × 100 mm triacetyl cellulose film (Fujitac, manufactured by Fuji Photo Film Co., Ltd.) was used as a substrate. An alkyl-modified polyvinyl alcohol (MP-203, manufactured by Kuraray Co., Ltd.) was applied on the substrate to a thickness of 0.5 μm, and dried and rubbed. Next, 100 parts by weight of the discotic liquid crystal compound (DLC) used in Example 1 in 400 parts by weight of methyl ethyl ketone, 1 part by weight of a copolymer obtained from the following fluorinated monomers M-1 and M-2, and the following polyfunctional monomer (M-3) A solution obtained by dissolving 10 parts by weight of a pyridinium quaternary salt was applied using a bar coater, and then dried at room temperature. The coating layer was heated to 125 degrees to align the liquid crystal compound, and the substrate was rapidly cooled to room temperature to fix the alignment state. The average tilt angle of the liquid crystal molecules was calculated by measuring the angle of the obtained thin film in the direction in which the retardation was minimized.
【0036】[0036]
【化16】 Embedded image
【0037】[0037]
【化17】 Embedded image
【0038】 使用傾斜制御剤 添加量(対液晶モル比) 平均傾斜角 未使用 ――― 33度 化合物1 0.3 36度 化合物2 0.3 36度 化合物3 0.3 37度 化合物4 0.3 37度 化合物5 0.3 35度 化合物6 0.3 37度 化合物7 0.3 35度 化合物8 0.3 37度 化合物9 0.3 36度 化合物10 0.3 37度 化合物11 0.3 36度 化合物12 0.3 37度 化合物13 0.3 36度 化合物14 0.3 35度 化合物15 0.3 37度 化合物16 0.3 38度 化合物17 0.3 38度 化合物18 0.3 37度 化合物19 0.3 36度 化合物20 0.3 36度 化合物21 0.3 38度Addition amount of tilt control agent used (molar ratio to liquid crystal) Average tilt angle Not used --- 33 degrees Compound 1 0.3 36 degrees Compound 2 0.3 36 degrees Compound 3 0.3 37 degrees Compound 40 3 37 degrees Compound 5 0.3 35 degrees Compound 6 0.3 37 degrees Compound 7 0.3 35 degrees Compound 8 0.3 37 degrees Compound 9 0.3 36 degrees Compound 10 0.3 37 degrees Compound 11 0.3 36 ° Compound 12 0.3 37 ° Compound 13 0.3 36 ° Compound 14 0.3 35 ° Compound 15 0.337 ° Compound 16 0.3 38 ° Compound 17 0.3 38 ° Compound 18 0.3 37 Degree Compound 19 0.3 36 Degree Compound 20 0.3 36 Degree Compound 21 0.3 38 Degree
【0039】[実施例3] (液晶傾斜角制御能の評価)ガラス基板上に配向膜とし
てサンエバー SE-610(日産化学(株))をバーコ
ーター(No4バー使用)で塗布し、乾燥、ラビング処理
を行った。次に、メチルエチルケトン(400重量部)
に実施例1で用いたディスコティック液晶化合物(10
0重量部)、セルロース アセテート ブチレート(1
重量部)と化合物3(対液晶モル比0.5)を溶解した
液をスピンコートで塗布した後、室温で乾燥した。液晶
層を200度に加熱した後、130度で液晶化合物を配
向し、その状態で基板を急速に室温まで冷却して配向状
態を固定した。液晶化合物をにおける観察と結晶回転法
に基づき、ディスコティック液晶化合物がラビング方向
に対して平行に並んで、基板に対して垂直(ホモジニア
ス)かつ均一(モノドメイン)に配向していることを確
認した。一方、コントロールとしてピリジニウム四級塩
を添加しなかった系では、均一な配向状態を取らなかっ
た。[Embodiment 3] (Evaluation of liquid crystal tilt angle controllability) Sunever SE-610 (Nissan Chemical Co., Ltd.) was applied as an alignment film on a glass substrate using a bar coater (using a No. 4 bar), dried and rubbed. Processing was performed. Next, methyl ethyl ketone (400 parts by weight)
The discotic liquid crystal compound used in Example 1 (10
0 parts by weight), cellulose acetate butyrate (1
Parts by weight) and Compound 3 (molar ratio to liquid crystal: 0.5) were applied by spin coating, and then dried at room temperature. After heating the liquid crystal layer to 200 degrees, the liquid crystal compound was aligned at 130 degrees, and in that state, the substrate was rapidly cooled to room temperature to fix the alignment state. Based on the observation of the liquid crystal compound and the crystal rotation method, it was confirmed that the discotic liquid crystal compounds were aligned parallel to the rubbing direction and were vertically (homogeneously) and uniformly (monodomain) aligned with the substrate. . On the other hand, in the system to which the pyridinium quaternary salt was not added as a control, a uniform alignment state was not obtained.
【0040】[実施例4] (液晶傾斜角制御能の評価)ガラス基板上に配向膜とし
てサンエバー SE-610(日産化学(株))をバーコ
ーター(No4バー使用)で塗布し、乾燥、ラビング処理
を行った。次に、メチルエチルケトン(400重量部)
に実施例1で用いたディスコティック液晶化合物(10
0重量部)と化合物3(対液晶モル比0.5)を溶解し
た液をスピンコートで塗布した後、室温で乾燥した。得
られた液晶層塗布基板に、ガラス基板上に配向膜として
サンエバー SE-610をバーコーターで塗布し、乾
燥、ラビング処理を行ったもう一枚のガラス基板をラビ
ング方向を180度回転して張り合わせた。次に、液晶
層を200度に加熱した後、130度で液晶化合物を配
向し、その状態で基板を急速に室温まで冷却して配向状
態を固定した。偏光顕微鏡における観察により液晶分子
がラビング方向に並んで基板に対して傾斜配向している
ことを確認し、結晶回転法に基づいて傾斜角を計測し
た。[Example 4] (Evaluation of liquid crystal tilt angle controllability) Sunever SE-610 (Nissan Chemical Co., Ltd.) was applied as an alignment film on a glass substrate using a bar coater (using a No. 4 bar), dried and rubbed. Processing was performed. Next, methyl ethyl ketone (400 parts by weight)
The discotic liquid crystal compound used in Example 1 (10
0 parts by weight) and a solution in which Compound 3 (molar ratio to liquid crystal was 0.5) was applied by spin coating, and then dried at room temperature. On the obtained liquid crystal layer coated substrate, Sanever SE-610 was coated as an alignment film on a glass substrate with a bar coater, and dried and rubbed, and another glass substrate was bonded by rotating the rubbing direction by 180 degrees. Was. Next, after the liquid crystal layer was heated to 200 degrees, the liquid crystal compound was aligned at 130 degrees, and in that state, the substrate was rapidly cooled to room temperature to fix the alignment state. Observation with a polarizing microscope confirmed that the liquid crystal molecules were aligned in the rubbing direction and tilted with respect to the substrate, and the tilt angle was measured based on the crystal rotation method.
【0041】 使用傾斜制御剤 平均傾斜角 未使用 32度 化合物3 40度Used tilt controlling agent Average tilt angle Unused 32 degrees Compound 3 40 degrees
【0042】[実施例5] (液晶傾斜角制御能の評価)化合物(2)および(3)
を用いて、実施例2と同様にして添加量と傾斜角の関係
を調べた。以下に示すように濃度依存的な傾斜角上昇が
確認された。Example 5 (Evaluation of ability to control liquid crystal tilt angle) Compounds (2) and (3)
The relationship between the amount of addition and the inclination angle was examined in the same manner as in Example 2 using. As shown below, a concentration-dependent increase in the tilt angle was confirmed.
【0043】 [0043]
【0044】 [0044]
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 2H090 HB07Y HD14 KA04 MA11 MB01 MB13 4C055 AA04 BA01 CA01 DA27 DB02 DB08 GA01 4H027 BA08 BD12 DA02 DM03 ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 2H090 HB07Y HD14 KA04 MA11 MB01 MB13 4C055 AA04 BA01 CA01 DA27 DB02 DB08 GA01 4H027 BA08 BD12 DA02 DM03
Claims (7)
し、液晶分子を配向させる方法であって、液晶層または
隣接する層に、ピリジニウム四級塩を添加し、ピリジニ
ウム四級塩の作用により液晶分子の傾斜角を制御するこ
とを特徴とする液晶分子の配向方法。1. A method for forming a liquid crystal layer containing liquid crystal molecules on a substrate and aligning the liquid crystal molecules, wherein a pyridinium quaternary salt is added to the liquid crystal layer or an adjacent layer, and the action of the pyridinium quaternary salt is performed. A method for aligning liquid crystal molecules, wherein the tilt angle of liquid crystal molecules is controlled by the method.
が、脂肪族アミノ基を置換基として有する請求項1に記
載の液晶分子の配向方法。2. The method for aligning liquid crystal molecules according to claim 1, wherein the pyridinium ring of the pyridinium quaternary salt has an aliphatic amino group as a substituent.
表される請求項1に記載の液晶分子の配向方法: 【化1】 [式中、R1 は、炭素原子数が1乃至30の脂肪族基で
あり;R2 およびR3 は、それぞれ独立に、炭素原子数
が1乃至8の脂肪族基であるか、あるいは、R2とR3
とが結合して含窒素複素環を形成し;そして、Xは、ア
ニオンである]。3. The method for aligning liquid crystal molecules according to claim 1, wherein the pyridinium quaternary salt is represented by the following formula (I): [Wherein, R 1 is an aliphatic group having 1 to 30 carbon atoms; R 2 and R 3 are each independently an aliphatic group having 1 to 8 carbon atoms, or R 2 and R 3
And X form a nitrogen-containing heterocyclic ring; and X is an anion.
表される請求項1に記載の液晶分子の配向方法: 【化2】 [式中、R1 は、炭素原子数が1乃至30の脂肪族基で
あり;R2 およびR3 は、それぞれ独立に、炭素原子数
が1乃至8の脂肪族基であるか、あるいは、R2とR3
とが結合して含窒素複素環を形成し;そして、Xは、ア
ニオンである]。4. The method for aligning liquid crystal molecules according to claim 1, wherein the pyridinium quaternary salt is represented by the following formula (II): [Wherein, R 1 is an aliphatic group having 1 to 30 carbon atoms; R 2 and R 3 are each independently an aliphatic group having 1 to 8 carbon atoms, or R 2 and R 3
And X form a nitrogen-containing heterocyclic ring; and X is an anion.
ル比で1/1000乃至250/1000の範囲で用い
る請求項1に記載の液晶分子の配向方法。5. The method for aligning liquid crystal molecules according to claim 1, wherein the pyridinium salt is used in a molar ratio to the liquid crystal molecules in the range of 1/1000 to 250/1000.
ある請求項1に記載の液晶分子の配向方法。6. The method according to claim 1, wherein the liquid crystal molecules are discotic liquid crystal molecules.
求項1に記載の液晶分子の配向方法。7. The method according to claim 1, wherein the liquid crystal molecules have a triphenylene nucleus.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000221114A JP4342704B2 (en) | 2000-07-21 | 2000-07-21 | Method for aligning liquid crystal molecules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000221114A JP4342704B2 (en) | 2000-07-21 | 2000-07-21 | Method for aligning liquid crystal molecules |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002038158A true JP2002038158A (en) | 2002-02-06 |
JP4342704B2 JP4342704B2 (en) | 2009-10-14 |
Family
ID=18715594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000221114A Expired - Fee Related JP4342704B2 (en) | 2000-07-21 | 2000-07-21 | Method for aligning liquid crystal molecules |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4342704B2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005061660A1 (en) * | 2003-12-15 | 2005-07-07 | Eastman Kodak Company | Aligned liquid crystal layer containing lewis acids |
WO2005061661A1 (en) * | 2003-12-15 | 2005-07-07 | Eastman Kodak Company | Liquid crystal layer containing azolium salt |
WO2005061662A1 (en) * | 2003-12-15 | 2005-07-07 | Eastman Kodak Company | Liquid crystal layer containing onium salt |
WO2006028187A1 (en) * | 2004-09-09 | 2006-03-16 | Fujifilm Corporation | Liquid crystal composition, optical compensation film and liquid crystal display device |
US7193087B2 (en) * | 2004-03-26 | 2007-03-20 | Fuji Photo Film Co., Ltd. | 4-Aminopyridinium compound |
JP2007171362A (en) * | 2005-12-20 | 2007-07-05 | Fujifilm Corp | Optical compensation film, polarizing plate, and liquid crystal display device |
JP2007178680A (en) * | 2005-12-27 | 2007-07-12 | Fujifilm Corp | Optical compensation film, polarizing plate, and liquid crystal display device |
US7311950B2 (en) | 2004-01-09 | 2007-12-25 | Fujifilm Corporation | Composition, optical compensatory film and liquid crystal display |
KR20200103041A (en) | 2017-12-21 | 2020-09-01 | 산텐 세이야꾸 가부시키가이샤 | Combination of Omidenepak |
KR20200103042A (en) | 2017-12-21 | 2020-09-01 | 산텐 세이야꾸 가부시키가이샤 | Combination medicine of cefetaprost and Rho kinase inhibitor |
JPWO2021132063A1 (en) * | 2019-12-27 | 2021-07-01 |
-
2000
- 2000-07-21 JP JP2000221114A patent/JP4342704B2/en not_active Expired - Fee Related
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005061661A1 (en) * | 2003-12-15 | 2005-07-07 | Eastman Kodak Company | Liquid crystal layer containing azolium salt |
WO2005061662A1 (en) * | 2003-12-15 | 2005-07-07 | Eastman Kodak Company | Liquid crystal layer containing onium salt |
JP2011065168A (en) * | 2003-12-15 | 2011-03-31 | Nitto Denko Corp | Aligned liquid crystal layer containing lewis acid |
WO2005061660A1 (en) * | 2003-12-15 | 2005-07-07 | Eastman Kodak Company | Aligned liquid crystal layer containing lewis acids |
US7097888B2 (en) | 2003-12-15 | 2006-08-29 | Eastman Kodak Company | Aligned liquid crystal layer containing azolium salts and process for increasing the tilt |
US7217445B2 (en) | 2003-12-15 | 2007-05-15 | Nitto Denko Corporation | Aligned liquid crystal layer containing Lewis acids and process for increasing the tilt |
JP2007515685A (en) * | 2003-12-15 | 2007-06-14 | 日東電工株式会社 | Aligned liquid crystal layer containing Lewis acid |
US7311950B2 (en) | 2004-01-09 | 2007-12-25 | Fujifilm Corporation | Composition, optical compensatory film and liquid crystal display |
US7193087B2 (en) * | 2004-03-26 | 2007-03-20 | Fuji Photo Film Co., Ltd. | 4-Aminopyridinium compound |
JP2006106662A (en) * | 2004-09-09 | 2006-04-20 | Fuji Photo Film Co Ltd | Liquid crystal composition, optically compensating film, and liquid crystal display device |
US7658864B2 (en) | 2004-09-09 | 2010-02-09 | Fujifilm Corporation | Liquid crystal composition, optical compensation film and liquid crystal display device |
WO2006028187A1 (en) * | 2004-09-09 | 2006-03-16 | Fujifilm Corporation | Liquid crystal composition, optical compensation film and liquid crystal display device |
KR101155363B1 (en) * | 2004-09-09 | 2012-06-19 | 후지필름 가부시키가이샤 | Liquid crystal composition, optical compensation film and liquid crystal display device |
JP2007171362A (en) * | 2005-12-20 | 2007-07-05 | Fujifilm Corp | Optical compensation film, polarizing plate, and liquid crystal display device |
JP2007178680A (en) * | 2005-12-27 | 2007-07-12 | Fujifilm Corp | Optical compensation film, polarizing plate, and liquid crystal display device |
KR20200103041A (en) | 2017-12-21 | 2020-09-01 | 산텐 세이야꾸 가부시키가이샤 | Combination of Omidenepak |
KR20200103042A (en) | 2017-12-21 | 2020-09-01 | 산텐 세이야꾸 가부시키가이샤 | Combination medicine of cefetaprost and Rho kinase inhibitor |
JPWO2021132063A1 (en) * | 2019-12-27 | 2021-07-01 | ||
US12130437B2 (en) | 2019-12-27 | 2024-10-29 | Fujifilm Corporation | Image display apparatus and AR glasses |
Also Published As
Publication number | Publication date |
---|---|
JP4342704B2 (en) | 2009-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1003821B1 (en) | Anisotropic retardation layers for display devices | |
JP4342704B2 (en) | Method for aligning liquid crystal molecules | |
US20110058127A1 (en) | Optical compensation sheet, polarizing plate, liquid crystal display and method of manufacturing optical compensation sheet | |
TWI421597B (en) | Optical film, optically compensatory film and polarizing plate and liquid crystal display using same | |
TWI403754B (en) | Optical film, polarizing plate and liquid crystal display device | |
JP2002062533A (en) | Method for aligning liquid crystal molecule | |
JP2000298210A (en) | Manufacture of long size optical compensation sheet | |
JP4153090B2 (en) | Optical compensation sheet manufacturing method | |
JP2002062531A (en) | Method for aligning liquid crystal molecule | |
TWI412843B (en) | Optical compensation film, polarizing plate and liquid crystal display | |
JP3996292B2 (en) | Liquid crystal display device and manufacturing method thereof | |
TWI420159B (en) | Optical compensation film and method of producing the same, polarizing plate and liquid crystal display | |
JPH08160429A (en) | Rubbing method, rubbing device and production of optical compensation sheet | |
TWI356212B (en) | Optical compensation film, liquid crystal display | |
JP4204597B2 (en) | Optical compensation sheet manufacturing method | |
JP3936434B2 (en) | Optical element manufacturing method | |
JPH09138413A (en) | Controlling method of orientation of molecule and liquid crystal display element | |
TWI325984B (en) | Liquid crystal display device | |
JP2001154194A (en) | Optical compensation sheet and liquid crystal display device utilizing the same | |
JP3616140B2 (en) | Optical compensation sheet manufacturing method | |
CN115989450A (en) | Optical film, circular polarizing plate, organic electroluminescent display device | |
JP4148611B2 (en) | Optical compensation sheet, elliptically polarizing plate, and liquid crystal display device | |
JP4654882B2 (en) | Anisotropic optical film manufacturing method, anisotropic optical film, and optical element | |
JPH08240713A (en) | Production of optical compensating film | |
JPH08160431A (en) | Rubbing method, rubbing device and production of optical compensation sheet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060320 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20061211 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090424 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090603 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090626 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090708 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120717 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4342704 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120717 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130717 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |